Medical Conditions That Block Weight Loss on Tirzepatide Hypothyroidism, polycystic ovary syndrome (PCOS), and insulin resistance can suppress weight loss even on adequate tirzepatide dosing
Mental and Emotional Benefits: Engaging in regular exercise has profound effects on mood and emotional well-being
HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA)
Cagrilintide represents the breakthrough next-generation amylin agonist with weekly dosing, 10-12% monotherapy weight loss, and proven synergy with GLP-1 agonists when combined
For example, the DURATION-8 study demonstrated that mean bodyweight loss with the combination of exenatide (GLP1-RA, which suppresses appetite) once weekly and dapagliflozin (SGLT2 inhibitor) once daily in patients with T2D was greater than that with the monotherapies alone [17]
Let's do lunch The biggest change to my lunch routine is my protein focus
